{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:42:15Z","timestamp":1794739335895,"version":"4.9.1"},"publisher-location":"Cham","reference-count":113,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031280115","type":"print"},{"value":"9783031280122","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-031-28012-2_25","type":"book-chapter","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T08:02:41Z","timestamp":1687939361000},"page":"457-476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Statins: Beneficial Effects in Treatment of COVID-19"],"prefix":"10.1007","author":[{"given":"Naser-Aldin","family":"Lashgari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin Momeni","family":"Roudsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedieh","family":"Shamsnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeideh","family":"Momtaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Abdolghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Matbou Riahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Guest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017deljko","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"issue":"4","key":"25_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2323","volume":"32","author":"W Saengsiwaritt","year":"2022","unstructured":"Saengsiwaritt W, Jittikoon J, Chaikledkaew U, et al (2022) Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis. Rev Med Virol 32(4):e2323. https:\/\/doi.org\/10.1002\/rmv.2323","journal-title":"Rev Med Virol"},{"issue":"8","key":"25_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/14728222.2020.1783243","volume":"24","author":"L Pearce","year":"2020","unstructured":"Pearce L, Davidson SM, Yellon DM (2020) The cytokine storm of COVID-19: a spotlight on prevention and protection. Expert Opin Ther Targets 24(8):723\u2013730","journal-title":"Expert Opin Ther Targets"},{"key":"25_CR3","doi-asserted-by":"publisher","first-page":"198347","DOI":"10.1016\/j.virusres","volume":"299","author":"M Altable","year":"2021","unstructured":"Altable M, de la Serna JM (2021) Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets. Virus Res 299:198347. https:\/\/doi.org\/10.1016\/j.virusres","journal-title":"Virus Res"},{"key":"25_CR4","doi-asserted-by":"publisher","unstructured":"Datta C, Bhattacharjee A (2020) Cytokine Storm and its Implication in Coronavirus disease 2019 (COVID-19). J Immunol Sci 4(3). https:\/\/doi.org\/10.1002\/jmv.26232","DOI":"10.1002\/jmv.26232"},{"key":"25_CR5","unstructured":"Cascella M, Rajnik M, Aleem A, et al (2022) Features, evaluation, and treatment of coronavirus (COVID-19). In: StatPearls [Internet]; StatPearls Publishing; Treasure Island, FL, USA)"},{"key":"25_CR6","doi-asserted-by":"publisher","unstructured":"Azmi NU, Puteri MU, Lukmanto D (2020) Cytokine storm in COVID-19: An overview, mechanism, treatment strategies, and stem cell therapy perspective. Pharm Sci Res 7(1). https:\/\/doi.org\/10.7454\/psr.v7i4.1092","DOI":"10.7454\/psr.v7i4.1092"},{"issue":"6","key":"25_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/14779072.2022.2081548","volume":"20","author":"LB Daniels","year":"2022","unstructured":"Daniels LB, Kumar K (2022) The role of statin therapy in COVID-19. Expert Rev Cardiovasc Ther 20(6):415\u2013417","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"5","key":"25_CR8","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.5114\/aoms\/141155","volume":"17","author":"M Khalifeh","year":"2021","unstructured":"Khalifeh M, Penson PE, Banach M, et al (2021) Statins as anti-pyroptotic agents. Arch Med Sci 17(5):1414\u20131417","journal-title":"Arch Med Sci"},{"issue":"3","key":"25_CR9","first-page":"546","volume":"114","author":"A Sahebkar","year":"2015","unstructured":"Sahebkar A, Serban C, Mikhailidis DP, et al (2015) Association between statin use and plasma d-dimer levels: A systematic review and meta-analysis of randomised controlled trials. J Thromb Haemost 114(3):546\u2013557","journal-title":"J Thromb Haemost"},{"key":"25_CR10","doi-asserted-by":"publisher","first-page":"9902","DOI":"10.1038\/srep09902","volume":"5","author":"C Serban","year":"2015","unstructured":"Serban C, Sahebkar A, Ursoniu S, et al (2015) A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. Sci Rep 5:9902. https:\/\/doi.org\/10.1038\/srep09902","journal-title":"Sci Rep"},{"issue":"5","key":"25_CR11","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.5114\/aoms.2019.89330","volume":"17","author":"SM Sohrevardi","year":"2021","unstructured":"Sohrevardi SM, Nasab FS, Mirjalili MR, et al (2021) Effect of atorvastatin on delirium status of patients in the intensive care unit: A randomized controlled trial. Arch Med Sci 17(5):1423. https:\/\/doi.org\/10.5114\/aoms.2019.89330","journal-title":"Arch Med Sci"},{"key":"25_CR12","doi-asserted-by":"publisher","first-page":"101024","DOI":"10.1016\/j.arr.2020.101024","volume":"58","author":"A Bahrami","year":"2020","unstructured":"Bahrami A, Bo S, Jamialahmadi T, et al (2020) Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ageing: Molecular mechanisms. Ageing Res Rev 58:101024. https:\/\/doi.org\/10.1016\/j.arr.2020.101024","journal-title":"Ageing Res Rev"},{"key":"25_CR13","doi-asserted-by":"publisher","first-page":"105986","DOI":"10.1016\/j.phrs.2021.105986","volume":"175","author":"AR Bland","year":"2022","unstructured":"Bland AR, Payne FM, Ashton JC, et al (2022) The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury. J Pharm Res 175:105986. https:\/\/doi.org\/10.1016\/j.phrs.2021.105986.","journal-title":"J Pharm Res"},{"issue":"8","key":"25_CR14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s40265-021-01510-4","volume":"81","author":"S Dehnavi","year":"2021","unstructured":"Dehnavi S, Kiani A, Sadeghi M, et al (2021) Targeting AMPK by Statins: A Potential Therapeutic Approach. Drugs 81(8):923\u2013933","journal-title":"Drugs"},{"issue":"5","key":"25_CR15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2174\/1874467214666210210123206","volume":"14","author":"AM Gorabi","year":"2021","unstructured":"Gorabi AM, Kiaie N, Bianconi V, et al (2021) Statins Attenuate Fibrotic Manifestations of Cardiac Tissue Damage. Curr Mol Pharmacol 14(5):782\u2013797","journal-title":"Curr Mol Pharmacol"},{"key":"25_CR16","doi-asserted-by":"publisher","first-page":"106284","DOI":"10.1016\/j.ejps.2022.106284","volume":"178","author":"A Hosseini","year":"2022","unstructured":"Hosseini A, Sahranavard T, Reiner \u017d, et al (2022) Effect of statins on abdominal aortic aneurysm. Eur J Pharm Sci 178:106284. https:\/\/doi.org\/10.1016\/j.ejps.2022.106284.","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"25_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11883-020-00837-9","volume":"22","author":"H Kouhpeikar","year":"2020","unstructured":"Kouhpeikar H, Delbari Z, Sathyapalan T, et al (2020) The Effect of Statins through Mast Cells in the Pathophysiology of Atherosclerosis: a Review. Curr Atheroscler Rep 22(5):19. https:\/\/doi.org\/10.1007\/s11883-020-00837-9","journal-title":"Curr Atheroscler Rep"},{"key":"25_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","volume":"1282","author":"AR Fehr","year":"2015","unstructured":"Fehr, A.R., Perlman, S. (2015) Coronaviruses: An Overview of their Replication and Pathogenesis. Methods Mol Biol 1282:1\u201323","journal-title":"Methods Mol Biol"},{"issue":"8","key":"25_CR19","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.3390\/v2081803","volume":"2","author":"PCY Woo","year":"2010","unstructured":"Woo PCY, Huang Y, Lau SKP, et al (2010) Coronavirus genomics and bioinformatics analysis. Viruses 2(8):1804\u20131820","journal-title":"Viruses"},{"key":"25_CR20","doi-asserted-by":"publisher","first-page":"117863612110024","DOI":"10.4103\/jfmpc.jfmpc_839_21","volume":"14","author":"NN Chathappady House","year":"2021","unstructured":"Chathappady House NN, Palissery S, Sebastian H (2021) Corona Viruses: A Review on SARS, MERS and COVID-19. Microbiol Insights 14:11786361211002481. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_839_21.","journal-title":"Microbiol Insights"},{"key":"25_CR21","unstructured":"Cherry J, Demmler-Harrison GJ, Kaplan SL, et al (2018) Feigin and Cherry\u2019s Textbook of Pediatric Infectious Diseases. Elsevier Health Sciences; Amsterdam, Netherlands. ISBN-13: 0323376921-978"},{"issue":"5","key":"25_CR22","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0022-2836(03)00865-9","volume":"331","author":"EJ Snijder","year":"2003","unstructured":"Snijder EJ, Bredenbeek PJ, Dobbe JC, et al (2003) Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 331(5):991\u20131004","journal-title":"J Mol Biol"},{"issue":"1","key":"25_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","volume":"174","author":"BW Neuman","year":"2011","unstructured":"Neuman BW, Kiss G, Kunding AH, et al (2011) A structural analysis of M protein in coronavirus assembly and morphology. J Struct Biol 174(1):11\u201322","journal-title":"J Struct Biol"},{"issue":"10","key":"25_CR24","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2174\/1389203722666210910111055","volume":"22","author":"CAK Cruz","year":"2021","unstructured":"Cruz CAK, Medina PMB (2021) Diversity in the Accessory Proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV Betacoronaviruses. Curr Protein Pept Sci 22(10):695\u2013715","journal-title":"Curr Protein Pept Sci"},{"issue":"1","key":"25_CR25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12931-020-01581-z","volume":"21","author":"M Rastogi","year":"2020","unstructured":"Rastogi M, Pandey N, Shukla A, et al (2020) SARS coronavirus 2: from genome to infectome. Respir Res 21(1):318. https:\/\/doi.org\/10.1186\/s12931-020-01581-z.","journal-title":"Respir Res"},{"key":"25_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/bs.aivir.2019.08.002","volume":"105","author":"MA Tortorici","year":"2019","unstructured":"Tortorici MA, Veesler D (2019) Structural insights into coronavirus entry. Adv Virus Res 105:93\u2013116","journal-title":"Adv Virus Res"},{"issue":"1","key":"25_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12931-020-01479-w","volume":"21","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Lian X, Su X, et al (2020) From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res 21(1):224. https:\/\/doi.org\/10.1186\/s12931-020-01479-w","journal-title":"Respir Res"},{"issue":"3","key":"25_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3769\/radioisotopes.31.3_166","volume":"31","author":"K Samukawa","year":"1982","unstructured":"Samukawa K (1982) [Use of stable isotopes in life science (III). Measurement of 15N abundance in amino acids with gas chromatography-mass spectrometry (author\u2019s transl)]. Radioisotopes 31(3):166\u2013174","journal-title":"Radioisotopes"},{"issue":"5","key":"25_CR29","first-page":"413","volume":"10","author":"DC Dooley","year":"1982","unstructured":"Dooley DC (1982) Glycerol permeation of the human granulocyte. Exp Hematol 10(5):413\u2013422","journal-title":"Exp Hematol"},{"issue":"7461","key":"25_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature12328","volume":"500","author":"G Lu","year":"2013","unstructured":"Lu G, Hu Y, Wang Q, et al (2013) Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 500(7461):227\u2013231","journal-title":"Nature"},{"issue":"25","key":"25_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2024815118","volume":"118","author":"R Sender","year":"2021","unstructured":"Sender R, Bar-On YM, Gleizer S, et al (2021) The total number and mass of SARS-CoV-2 virions. Proc Natl Acad Sci 118(25):e2024815118. https:\/\/doi.org\/10.1073\/pnas.2024815118","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"25_CR32","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3201\/eid1002.030913","volume":"10","author":"CS Goldsmith","year":"2004","unstructured":"Goldsmith CS, Tatti KM, Ksiazek TG, et al (2004) Ultrastructural characterization of SARS coronavirus. Emerg Infect Dis 10(2):320\u2013326","journal-title":"Emerg Infect Dis"},{"key":"25_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-981-15-4814-7_3","volume":"COVID-19","author":"S Kumar","year":"2019","unstructured":"Kumar S, Nyodu R, Maurya VK, et al. Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Coronavirus Disease 2019 (COVID-19):23\u201331. https:\/\/doi.org\/10.1007\/978-981-15-4814-7_3","journal-title":"Coronavirus Disease"},{"issue":"7838","key":"25_CR34","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41586-020-2665-2","volume":"588","author":"Z Ke","year":"2020","unstructured":"Ke Z, Oton J, Qu K, et al (2020) Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature 588(7838):498\u2013502","journal-title":"Nature"},{"issue":"1","key":"25_CR35","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1038\/s41467-020-18440-6","volume":"11","author":"DL Hurdiss","year":"2020","unstructured":"Hurdiss DL, Drulyte I, Lang Y, et al (2020) Cryo-EM structure of coronavirus-HKU1 haemagglutinin esterase reveals architectural changes arising from prolonged circulation in humans. Nat Commun 11(1):4646. https:\/\/doi.org\/10.1038\/s41467-020-18440-6","journal-title":"Nat Commun"},{"issue":"12","key":"25_CR36","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s41594-020-00536-8","volume":"27","author":"VS Mandala","year":"2020","unstructured":"Mandala VS, McKay MJ, Shcherbakov AA, et al (2020) Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. Nat Struct Mol Biol 27(12):1202\u20131208","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"25_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S1672-0229(03)01016-7","volume":"1","author":"Y Hu","year":"2003","unstructured":"Hu Y, Wen J, Tang L, et al (2003) The M protein of SARS-CoV: basic structural and immunological properties. Genomics Proteomics Bioinformatics 1(2):118\u2013130","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"24","key":"25_CR38","doi-asserted-by":"publisher","first-page":"15054","DOI":"10.1128\/JVI.79.24.15054-15063.2005","volume":"79","author":"A Lissenberg","year":"2005","unstructured":"Lissenberg A, Vrolijk MM, van Vliet AL, et al (2005) Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory haemagglutinin esterase protein display reduced fitness in vitro. J Virol 79(24):15054\u201315063","journal-title":"J Virol"},{"issue":"9","key":"25_CR39","first-page":"3409","volume":"39","author":"S Boopathi","year":"2021","unstructured":"Boopathi S, Poma AB, Kolandaivel P (2021) Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn 39(9):3409\u20133418","journal-title":"J Biomol Struct Dyn"},{"issue":"24","key":"25_CR40","doi-asserted-by":"publisher","first-page":"12491","DOI":"10.1128\/JVI.76.24.12491-12502.2002","volume":"76","author":"CAM de Haan","year":"2002","unstructured":"de Haan CAM, Volders H, Koetzner CA, et al (2002) Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization. J Virol 76(24):12491\u201312502.","journal-title":"J Virol"},{"issue":"6","key":"25_CR41","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/jmv.25754","volume":"92","author":"M Kandeel","year":"2020","unstructured":"Kandeel M, Ibrahim A, Fayez M, et al (2020) From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes. J Med Virol 92(6):660\u2013666","journal-title":"J Med Virol"},{"key":"25_CR42","doi-asserted-by":"publisher","first-page":"117793222110258","DOI":"10.1177\/11779322211025876","volume":"15","author":"R Gorkhali","year":"2021","unstructured":"Gorkhali R, Koirala P, Rijal S, et al (2021) Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins. Bioinform Biol 15:11779322211025876. https:\/\/doi.org\/10.1177\/11779322211025876.","journal-title":"Bioinform Biol"},{"issue":"5","key":"25_CR43","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3390\/cells9051267","volume":"9","author":"M Romano","year":"2020","unstructured":"Romano M, Ruggiero A, Squeglia F, et al (2020) A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping. Cells 9(5):1267. https:\/\/doi.org\/10.3390\/cells9051267.","journal-title":"Cells"},{"issue":"21","key":"25_CR44","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang J, Wan Y, Luo C, et al (2020) Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA 117(21):11727\u201311734","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"25_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000054","volume":"4","author":"MJ van Hemert","year":"2008","unstructured":"van Hemert MJ, van den Worm SH, Knoops K, et al (2008) SARS-coronavirus replication\/transcription complexes are membrane-protected and need a host factor for activity in vitro. PLoS Pathog 4(5):e1000054. https:\/\/doi.org\/10.1371\/journal.ppat.1000054.","journal-title":"PLoS Pathog"},{"issue":"3","key":"25_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu B, Guo H, Zhou P, et al (2021) Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 19(3):141\u2013154","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"25_CR47","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/v11030210","volume":"11","author":"Y Fan","year":"2019","unstructured":"Fan Y, Zhao K, Shi ZL, et al (2019) Bat Coronaviruses in China. Viruses 11(3):210. https:\/\/doi.org\/10.3390\/v11030210.","journal-title":"Viruses"},{"key":"25_CR48","doi-asserted-by":"publisher","unstructured":"Payne S. Family Coronaviridae. Viruses. 2017:149\u2013158. https:\/\/doi.org\/10.1016\/B978-0-12-803109-4.00017-9","DOI":"10.1016\/B978-0-12-803109-4.00017-9"},{"key":"25_CR49","unstructured":"International Committee on Taxonomy of Viruses (ICTV). https:\/\/ictv.global\/. Accessed Oct 14, 2022"},{"key":"25_CR50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","volume":"100","author":"VM Corman","year":"2018","unstructured":"Corman VM, Muth D, Niemeyer D, et al (2018) Hosts and Sources of Endemic Human Coronaviruses. Adv Virus Res 100:163\u2013188","journal-title":"Adv Virus Res"},{"issue":"3","key":"25_CR51","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7423","volume":"2","author":"M Pal","year":"2020","unstructured":"Pal M, Berhanu G, Desalegn C, et al (2020) Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update. Cureus 2(3):e7423. https:\/\/doi.org\/10.7759\/cureus.7423","journal-title":"Cureus"},{"key":"25_CR52","unstructured":"World Health Organization; Tracking SARS-CoV-2 variants. https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants. Accessed October 24, 2022"},{"issue":"7","key":"25_CR53","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s41564-021-00932-w","volume":"6","author":"F Konings","year":"2021","unstructured":"Konings F, Perkins MD, Kuhn JH, et al (2021) SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse. Nat Rev Microbiol 6(7):821\u2013823","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"25_CR54","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41440-020-0476-3","volume":"43","author":"F Silhol","year":"2020","unstructured":"Silhol F, Sarlon G, Deharo JC, et al (2020) Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system? Hypertens Res 43(8):854\u2013856","journal-title":"Hypertens Res"},{"key":"25_CR55","doi-asserted-by":"publisher","first-page":"104673","DOI":"10.1016\/j.micpath.2020.104673","volume":"150","author":"S Choudhary","year":"2021","unstructured":"Choudhary S, Sharma K, Silakari O (2021) The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options. Microb Pathog 150:104673. https:\/\/doi.org\/10.1016\/j.micpath.2020.104673.","journal-title":"Microb Pathog"},{"key":"25_CR56","doi-asserted-by":"publisher","first-page":"112420","DOI":"10.1016\/j.biopha.2021.112420","volume":"145","author":"M Farahani","year":"2022","unstructured":"Farahani M, Niknam Z, Mohammadi Amirabad L, et al (2022) Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. Biomed Pharmacother 145:112420. https:\/\/doi.org\/10.1016\/j.biopha.2021.112420.","journal-title":"Biomed Pharmacother"},{"key":"25_CR57","doi-asserted-by":"publisher","first-page":"173620","DOI":"10.1016\/j.ejphar.2020.173620","volume":"890","author":"A Yarmohammadi","year":"2021","unstructured":"Yarmohammadi A, Yarmohammadi M, Fakhri S, et al (2021) Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review. Eur J Pharmacol 890:173620. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173620.","journal-title":"Eur J Pharmacol"},{"key":"25_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006401.pub5","volume":"11","author":"A Vuorio","year":"2019","unstructured":"Vuorio A, Kuoppala J, Kovanen PT, et al (2019) Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev (11):CD006401. https:\/\/doi.org\/10.1002\/14651858.CD006401.pub5.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"25_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.14797\/mdcj-15-1-23","volume":"15","author":"PP Toth","year":"2019","unstructured":"Toth PP, Banach M (2019) Statins: Then and Now. Methodist Debakey Cardiovasc J 15(1):23\u201331","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"1","key":"25_CR60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1567-5688(03)00003-5","volume":"4","author":"E Istvan","year":"2003","unstructured":"Istvan E (2003) Statin inhibition of HMG-CoA reductase: a 3-dimensional view. Atheroscler Suppl 4(1):3\u20138","journal-title":"Atheroscler Suppl"},{"issue":"1","key":"25_CR61","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJM198807073190105","volume":"319","author":"SM Grundy","year":"1988","unstructured":"Grundy SM (1988) HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med 319(1):24\u201333","journal-title":"N Engl J Med"},{"issue":"4","key":"25_CR62","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00253-009-2239-6","volume":"85","author":"J Barrios-Gonz\u00e1lez","year":"2005","unstructured":"Barrios-Gonz\u00e1lez J, Miranda RU (2005) Biotechnological production and applications of statins. Appl Microbiol Biotechnol 85(4):869\u2013883","journal-title":"Appl Microbiol Biotechnol"},{"key":"25_CR63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","volume":"1","author":"M Schachter","year":"2005","unstructured":"Schachter M (2005) Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol (1):117\u2013125","journal-title":"Fundam Clin Pharmacol"},{"key":"25_CR64","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2165\/00003088-199631050-00003","volume":"5","author":"JP Desager","year":"1996","unstructured":"Desager JP, Horsmans Y (1996) Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Clin Pharmacokinet (5):348\u2013371","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"25_CR65","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2165\/00003088-199732050-00005","volume":"32","author":"H Lennern\u00e4s","year":"1997","unstructured":"Lennern\u00e4s H, Fager G (1997) Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmacokinet 32(5):403\u2013425","journal-title":"Clin Pharmacokinet"},{"key":"25_CR66","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/MOL.0b013e3283453e41","volume":"3","author":"DX Bu","year":"2011","unstructured":"Bu DX, Griffin G, Lichtman AH (2011) Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol (3):165\u2013170","journal-title":"Curr Opin Lipidol"},{"key":"25_CR67","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/01.mca.0000131573.31966.34","volume":"5","author":"J Davignon","year":"2004","unstructured":"Davignon J, Jacob RF, Mason RP (2004) The antioxidant effects of statins. Coron Artery Dis (5):251\u2013258","journal-title":"Coron Artery Dis"},{"issue":"4","key":"25_CR68","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11745-010-3517-x","volume":"46","author":"SMR Parizadeh","year":"2011","unstructured":"Parizadeh SMR, Azarpazhooh MR, Moohebati M, et al (2011) Simvastatin therapy reduces prooxidant-antioxidant balance: Results of a placebo-controlled cross-over trial. Lipids 46(4):333\u2013340","journal-title":"Lipids"},{"issue":"11","key":"25_CR69","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2174\/138161212799504803","volume":"18","author":"AS Antonopoulos","year":"2012","unstructured":"Antonopoulos AS, Margaritis M, Lee R, et al (2012) Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des 18(11):1519\u20131530","journal-title":"Curr Pharm Des"},{"issue":"4","key":"25_CR70","doi-asserted-by":"publisher","first-page":"622","DOI":"10.5114\/aoms.2013.36905","volume":"9","author":"J Sikora","year":"2013","unstructured":"Sikora J, Kostka B, Marczyk I, et al (2013) Effect of statins on platelet function in patients with hyperlipidemia. Arch Med Sci 9(4):622\u2013628","journal-title":"Arch Med Sci"},{"issue":"5","key":"25_CR71","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1161\/01.CIR.95.5.1126","volume":"95","author":"G O\u2019Driscoll","year":"2017","unstructured":"O\u2019Driscoll G, Green D, Taylor RR (2017) Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95(5):1126\u20131131","journal-title":"Circulation"},{"issue":"1","key":"25_CR72","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.expneurol.2010.04.006","volume":"230","author":"Q Wang","year":"2011","unstructured":"Wang Q, Yan J, Chen X, et al (2011) Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Exp Neurol 230(1):27\u201334","journal-title":"Exp Neurol"},{"issue":"6","key":"25_CR73","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","volume":"8","author":"BA Golomb","year":"2008","unstructured":"Golomb BA, Evans MA (2008) Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs 8(6):373\u2013418","journal-title":"Am J Cardiovasc Drugs"},{"issue":"7","key":"25_CR74","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/qjmed\/92.7.387","volume":"92","author":"AS Wierzbicki","year":"1999","unstructured":"Wierzbicki AS, Lumb PJ, Semra Y, Chik G, et al (1999) Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias. QJM 92(7):387\u201394.","journal-title":"QJM"},{"issue":"13","key":"25_CR75","first-page":"1514","volume":"105","author":"AMJC Gotto Jr","year":"2002","unstructured":"Gotto Jr AMJC (2002) Statins: powerful drugs for lowering cholesterol: advice for patients. Am Heart J 105(13):1514\u20131516","journal-title":"Am Heart J"},{"key":"25_CR76","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","volume":"45","author":"JK Liao","year":"2005","unstructured":"Liao JK, Laufs U (2005) Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45:89\u2013118","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"25_CR77","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.atherosclerosis.2008.08.022","volume":"203","author":"A Blum","year":"2009","unstructured":"Blum A, Shamburek R (2009) The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis 203(2):325\u2013330","journal-title":"Atherosclerosis"},{"issue":"13","key":"25_CR78","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","volume":"295","author":"SE Nissen","year":"2006","unstructured":"Nissen SE, Nicholls SJ, Sipahi I, et al (2006) Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295(13):1556\u20131565","journal-title":"JAMA"},{"issue":"21","key":"25_CR79","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FA, et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359(21):2195\u20132207","journal-title":"N Engl J Med"},{"key":"25_CR80","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2147\/DDDT.S10812","volume":"4","author":"R Kones","year":"2010","unstructured":"Kones R (2010) Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective. Drug Des Devel Ther 4:383\u2013413","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"25_CR81","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2004.07.003","volume":"177","author":"E Ascer","year":"2004","unstructured":"Ascer E, Bertolami MC, Venturinelli ML, et al (2004) Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. Atherosclerosis 177(1):161\u2013166","journal-title":"Atherosclerosis"},{"issue":"1","key":"25_CR82","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0021-9150(02)00316-7","volume":"166","author":"MA van de Ree","year":"2003","unstructured":"van de Ree MA, Huisman MV, Princen HM, et al (2003) Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. Atherosclerosis 166(1):129\u2013135","journal-title":"Atherosclerosis"},{"issue":"1","key":"25_CR83","first-page":"49","volume":"27","author":"P Chansrichavala","year":"2009","unstructured":"Chansrichavala P, Chantharaksri U, Sritara P, et al (2009) Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway. Asian Pac J Allergy Immunol 27(1):49\u201357","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"19","key":"25_CR84","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1001\/archinte.164.19.2162","volume":"164","author":"FA Spencer","year":"2004","unstructured":"Spencer FA, Fonarow GC, Frederick PD, et al (2004) Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction. Arch Intern Med 164(19):2162\u20132168","journal-title":"Arch Intern Med"},{"issue":"12","key":"25_CR85","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1161\/01.CIR.0000012530.68333.C8","volume":"105","author":"C Heeschen","year":"2002","unstructured":"Heeschen C, Hamm CW, Laufs U, et al (2002) Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 105(12):1446\u20131452","journal-title":"Circulation"},{"issue":"2","key":"25_CR86","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1128\/JVI.02576-13","volume":"88","author":"ML DeDiego","year":"2013","unstructured":"DeDiego ML, Nieto-Torres J, Regla-Nava JA, et al (2013) Inhibition of NF- B-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival. J Virol 88(2):913\u201324","journal-title":"J Virol"},{"key":"25_CR87","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.764","volume":"3","author":"TR Cimato","year":"2015","unstructured":"Cimato TR, Palka BA (2015) Effects of statins on TH1 modulating cytokines in human subjects. PeerJ;3:e764. https:\/\/doi.org\/10.7717\/peerj.764.","journal-title":"PeerJ"},{"issue":"4","key":"25_CR88","doi-asserted-by":"publisher","first-page":"e01120","DOI":"10.1128\/mBio.01120-15","volume":"6","author":"S Yuan","year":"2015","unstructured":"Yuan S (2015) Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection. mBio 6(4):e01120. https:\/\/doi.org\/10.1128\/mBio.01120-15.","journal-title":"mBio"},{"key":"25_CR89","doi-asserted-by":"publisher","first-page":"138","DOI":"10.23937\/2377-3634\/1410138","volume":"8","author":"M Jammal","year":"2022","unstructured":"Jammal M, Riachy M, Haddad F (2022) Can statins be beneficial in Covid 19 patients? Int J Diabetes Clin Res 8:138. https:\/\/doi.org\/10.23937\/2377-3634\/1410138","journal-title":"Int J Diabetes Clin Res"},{"issue":"2","key":"25_CR90","doi-asserted-by":"publisher","first-page":"490","DOI":"10.5114\/aoms.2020.94655","volume":"16","author":"\u017d Reiner","year":"2020","unstructured":"Reiner \u017d, Hatamipour M, Banach M, et al (2020) Statins and the Covid-19 main protease: In silico evidence on direct interaction. Arch Med Sci 16(2):490\u2013496","journal-title":"Arch Med Sci"},{"issue":"3","key":"25_CR91","doi-asserted-by":"publisher","first-page":"579","DOI":"10.5114\/aoms\/132950","volume":"17","author":"A Vahedian-Azimi","year":"2021","unstructured":"Vahedian-Azimi A, Mohammadi SM, Beni FH, et al (2021) Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: A systematic review and meta-analysis. Arch Med Sci 17(3):579\u2013595","journal-title":"Arch Med Sci"},{"issue":"Pt A","key":"25_CR92","doi-asserted-by":"publisher","first-page":"108192","DOI":"10.1016\/j.intimp.2021.108192","volume":"101","author":"S Karampoor","year":"2021","unstructured":"Karampoor S, Hesamizadeh K, Shams Z, et al (2021) The role of lovastatin in the attenuation of COVID-19. Int Immunopharmacol 101(Pt A):108192. https:\/\/doi.org\/10.1016\/j.intimp.2021.108192","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"25_CR93","doi-asserted-by":"publisher","first-page":"579","DOI":"10.5114\/aoms\/132950","volume":"17","author":"A Vahedian-Azimi","year":"2021","unstructured":"Vahedian-Azimi A, Mohammadi SM, Heidari Beni F, et al (2021) Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis. Arch Med Sci 17(3):579\u201395","journal-title":"Arch Med Sci"},{"issue":"12","key":"25_CR94","doi-asserted-by":"publisher","first-page":"103469","DOI":"10.1016\/j.isci.2021.103469","volume":"24","author":"FJ Zapatero-Belinch\u00f3n","year":"2021","unstructured":"Zapatero-Belinch\u00f3n FJ, Moeller R, Lasswitz L, et al (2021) Fluvastatin mitigates SARS-CoV-2 infection in human lung cells. iScience 24(12):103469. https:\/\/doi.org\/10.1016\/j.isci.2021.103469","journal-title":"iScience"},{"issue":"1","key":"25_CR95","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13054-020-03154-4","volume":"24","author":"G Rodriguez-Nava","year":"2020","unstructured":"Rodriguez-Nava G, Trelles-Garcia DP, Yanez-Bello MA, et al (2020) Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study. Crit Care 24(1):429. https:\/\/doi.org\/10.1186\/s13054-020-03154-4.","journal-title":"Crit Care"},{"issue":"9","key":"25_CR96","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14434","volume":"75","author":"M Haji Aghajani","year":"2021","unstructured":"Haji Aghajani M, Moradi O, Azhdari Tehrani H, et al (2021) Promising effects of atorvastatin on mortality and need for mechanical ventilation in patients with severe COVID-19; a retrospective cohort study. Int J Clin Pract 75(9):e14434. https:\/\/doi.org\/10.1111\/ijcp.14434","journal-title":"Int J Clin Pract"},{"key":"25_CR97","doi-asserted-by":"publisher","first-page":"100875","DOI":"10.1016\/j.ijcha.2021.100875","volume":"36","author":"L Davoodi","year":"2021","unstructured":"Davoodi L, Jafarpour H, Oladi Z, et al (2021) Atorvastatin therapy in COVID-19 adult inpatients: A double-blind, randomized controlled trial. Int J Cardiol Heart Vasc 36:100875. https:\/\/doi.org\/10.1016\/j.ijcha.2021.100875","journal-title":"Int J Cardiol Heart Vasc"},{"key":"25_CR98","doi-asserted-by":"publisher","unstructured":"INSPIRATION Investigators (2022) Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial. 2022;376. BMJ 376:e068407. https:\/\/doi.org\/10.1136\/bmj-2021-068407","DOI":"10.1136\/bmj-2021-068407"},{"issue":"7","key":"25_CR99","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/jmv.27710","volume":"94","author":"M Ghafoori","year":"2022","unstructured":"Ghafoori M, Saadati H, Taghavi M, et al (2022) Survival of the hospitalized patients with COVID-19 receiving atorvastatin: A randomized clinical trial. J Med Virol 94(7):3160\u20133168","journal-title":"J Med Virol"},{"issue":"3","key":"25_CR100","doi-asserted-by":"publisher","first-page":"490","DOI":"10.5114\/aoms.2020.94655","volume":"16","author":"\u017d Reiner","year":"2020","unstructured":"Reiner \u017d, Hatamipour M, Banach M, et al (2020) Statins and the COVID-19 main protease: in silico evidence on direct interaction. Arch Med Sci 16(3):490\u2013496","journal-title":"Arch Med Sci"},{"key":"25_CR101","doi-asserted-by":"crossref","unstructured":"Sapey E, Patel JM, Greenwood HL, et al. Pulmonary Infections in the Elderly Lead to Impaired Neutrophil Targeting, Which Is Improved by Simvastatin. Am J Respir Crit Care Med 196(10):1325\u20131336","DOI":"10.1164\/rccm.201704-0814OC"},{"issue":"3","key":"25_CR102","doi-asserted-by":"publisher","first-page":"e00660","DOI":"10.1128\/mBio.00660-18","volume":"9","author":"P Shrivastava-Ranjan","year":"2018","unstructured":"Shrivastava-Ranjan P, Flint M, Bergeron \u00c9, et al (2018) Statins suppress Ebola virus infectivity by interfering with glycoprotein processing. mBio 9(3):e00660\u201318. https:\/\/doi.org\/10.1128\/mBio.00660-18","journal-title":"mBio"},{"issue":"1","key":"25_CR103","doi-asserted-by":"publisher","first-page":"e0170123","DOI":"10.1371\/journal.pone.0170123","volume":"12","author":"H Guo","year":"2017","unstructured":"Guo H, Huang M, Yuan Q, et al (2017) The Important Role of Lipid Raft-Mediated Attachment in the Infection of Cultured Cells by Coronavirus Infectious Bronchitis Virus Beaudette Strain. PLoS One;12(1):e0170123. https:\/\/doi.org\/10.1371\/journal.pone.0170123.","journal-title":"PLoS One"},{"issue":"6","key":"25_CR104","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.5114\/aoms.2020.100304","volume":"16","author":"N Shakour","year":"2020","unstructured":"Shakour N, Ruscica M, Hadizadeh F, et al (2020) Statins and C-reactive protein: In silico evidence on direct interaction. Arch Med Sci 16(6):1432\u20131439","journal-title":"Arch Med Sci"},{"issue":"2","key":"25_CR105","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/cr.2008.15","volume":"18","author":"H Wang","year":"2008","unstructured":"Wang, H, Yang, P, Liu, K, et al (2008) SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res 18(2):290\u2013301","journal-title":"Cell Res"},{"key":"25_CR108","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068407","volume":"376","author":"INSPIRATION-S Investigators","year":"2022","unstructured":"INSPIRATION-S Investigators (2022) Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial. BMJ 376:e068407. https:\/\/doi.org\/10.1136\/bmj-2021-068407","journal-title":"BMJ"},{"key":"25_CR109","doi-asserted-by":"publisher","unstructured":"Gait\u00e1n-Duarte HG, \u00c1lvarez-Moreno C, Rinc\u00f3n-Rodr\u00edguez CJ, et al (2021) Effectiveness of Rosuvastatin plus Colchicine, Emtricitabine\/Tenofovir and a combination of them in Hospitalized Patients with SARS Covid-19. medRxiv https:\/\/doi.org\/10.1101\/2021.07.06.21260085","DOI":"10.1101\/2021.07.06.21260085"},{"key":"25_CR110","doi-asserted-by":"publisher","unstructured":"Hayden MR (2020) An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of beta-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms. Cells 9(11). https:\/\/doi.org\/10.3390\/cells9112475","DOI":"10.3390\/cells9112475"},{"key":"25_CR111","doi-asserted-by":"publisher","first-page":"104891","DOI":"10.1016\/j.phrs.2020.104891","volume":"158","author":"M Banach","year":"2020","unstructured":"Banach M, Penson PE, Fras Z, et al (2020) Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. Pharmacol Res 158:104891. https:\/\/doi.org\/10.1016\/j.phrs.2020.104891","journal-title":"Pharmacol Res"},{"issue":"6569","key":"25_CR112","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1126\/science.acx9605","volume":"374","author":"J Couzin-Frankel","year":"2021","unstructured":"Couzin-Frankel J (2021) Antiviral pills could change pandemic\u2019s course. Science 374(6569):799\u2013800, https:\/\/doi.org\/10.1126\/science.acx9605","journal-title":"Science"},{"issue":"7","key":"25_CR113","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","volume":"21","author":"C Menni","year":"2021","unstructured":"Menni C, Klaser K, May A, et al (2021) Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis 21(7):939\u2013949","journal-title":"Lancet Infect Dis"},{"key":"25_CR114","doi-asserted-by":"publisher","first-page":"820131","DOI":"10.3389\/fimmu.2022.820131","volume":"13","author":"L Teixeira","year":"2022","unstructured":"Teixeira L, Temerozo JR, Pereira-Dutra FS, et al (2022) Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts. Front Immunol 13:820131. https:\/\/doi.org\/10.3389\/fimmu.2022.820131","journal-title":"Front Immunol"},{"issue":"23","key":"25_CR115","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01396-21","volume":"95","author":"Y Qian","year":"2021","unstructured":"Qian Y, Lei T, Patel PS, et al (2021) Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin. J Virol 95(23):e0139621. https:\/\/doi.org\/10.1128\/JVI.01396-21.","journal-title":"J Virol"}],"container-title":["Advances in Experimental Medicine and Biology","Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-28012-2_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T08:07:13Z","timestamp":1687939633000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-28012-2_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031280115","9783031280122"],"references-count":113,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-28012-2_25","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-031-28012-2","asserted-by":"object"}]},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"29 June 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}